Jon Olson

1.9k total citations
17 papers, 671 citations indexed

About

Jon Olson is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jon Olson has authored 17 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jon Olson's work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (8 papers) and Nail Diseases and Treatments (3 papers). Jon Olson is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (8 papers) and Nail Diseases and Treatments (3 papers). Jon Olson collaborates with scholars based in United States, Australia and Netherlands. Jon Olson's co-authors include Jill Adler‐Moore, Richard T. Proffitt, Julie Schwartz, Gerard M. Jensen, Peter J. Smith, Neil A. R. Gow, Louise A. Walker, Julie M. Wolf, Prashant Sood and Arturo Casadevall and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jon Olson

17 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Olson United States 13 354 278 159 64 61 17 671
Arsa Thammahong Thailand 14 285 0.8× 219 0.8× 220 1.4× 23 0.4× 75 1.2× 30 631
Marcin G. Fraczek United Kingdom 17 727 2.1× 436 1.6× 306 1.9× 79 1.2× 107 1.8× 25 1.2k
Dirk Wartenberg Germany 9 192 0.5× 135 0.5× 191 1.2× 16 0.3× 52 0.9× 9 466
F. Van Gerven Belgium 18 586 1.7× 643 2.3× 88 0.6× 17 0.3× 110 1.8× 31 1.1k
José Pedro Lopes Sweden 8 288 0.8× 180 0.6× 125 0.8× 21 0.3× 28 0.5× 11 547
Veronica M. Hearn United Kingdom 20 544 1.5× 371 1.3× 369 2.3× 27 0.4× 48 0.8× 46 1.0k
Urszula Nawrot Poland 13 176 0.5× 167 0.6× 51 0.3× 35 0.5× 21 0.3× 44 397
Marcia L. Sokol-Anderson United States 9 250 0.7× 186 0.7× 83 0.5× 8 0.1× 60 1.0× 12 425
Nanda de Groot Netherlands 14 254 0.7× 141 0.5× 499 3.1× 29 0.5× 10 0.2× 22 956
Montserrat Ortoneda Spain 17 444 1.3× 398 1.4× 92 0.6× 6 0.1× 61 1.0× 21 766

Countries citing papers authored by Jon Olson

Since Specialization
Citations

This map shows the geographic impact of Jon Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Olson more than expected).

Fields of papers citing papers by Jon Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Olson. The network helps show where Jon Olson may publish in the future.

Co-authorship network of co-authors of Jon Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Olson. A scholar is included among the top collaborators of Jon Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Olson. Jon Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Olson, Jon, et al.. (2020). Effect of testosterone and estrogen supplementation on the resistance to systemic Candida albicans infection in mice. Heliyon. 6(7). e04437–e04437. 10 indexed citations
3.
Walker, Louise A., Prashant Sood, Megan D. Lenardon, et al.. (2018). The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles. mBio. 9(1). 136 indexed citations
4.
Adler‐Moore, Jill, Richard T. Proffitt, Jon Olson, & Greg Jensen. (2017). Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens. Journal of Liposome Research. 27(3). 195–209. 15 indexed citations
5.
Blumstein, Gideon, et al.. (2014). Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection. PLoS ONE. 9(7). e103288–e103288. 6 indexed citations
6.
8.
Olson, Jon, et al.. (2010). Liposomal Amphotericin B and Echinocandins as Monotherapy or Sequential or Concomitant Therapy in Murine Disseminated and Pulmonary Aspergillus fumigatus Infections. Antimicrobial Agents and Chemotherapy. 54(9). 3884–3894. 25 indexed citations
10.
Smith, Peter J., et al.. (2007). Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B. Journal of Antimicrobial Chemotherapy. 59(5). 941–951. 55 indexed citations
11.
Olson, Jon, Jill Adler‐Moore, Gerard M. Jensen, et al.. (2007). Comparison of the Physicochemical, Antifungal, and Toxic Properties of Two Liposomal Amphotericin B Products. Antimicrobial Agents and Chemotherapy. 52(1). 259–268. 58 indexed citations
12.
Camacho, Luis H., Jon Olson, William P. Tong, et al.. (2006). Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors. Investigational New Drugs. 25(2). 131–138. 75 indexed citations
13.
Olson, Jon, Jill Adler‐Moore, Julie Schwartz, Gerard M. Jensen, & Richard T. Proffitt. (2006). Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model. Antimicrobial Agents and Chemotherapy. 50(6). 2122–2131. 59 indexed citations
14.
Olson, Jon, Jill Adler‐Moore, Peter J. Smith, & Richard T. Proffitt. (2005). Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin. Antimicrobial Agents and Chemotherapy. 49(12). 4895–4902. 64 indexed citations
15.
Adler‐Moore, Jill, Jon Olson, & Richard T. Proffitt. (2004). Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Journal of Antimicrobial Chemotherapy. 54(6). 1096–1102. 26 indexed citations
16.
Lehrer, Samuel B., Manuel Lopez, Brian T. Butcher, et al.. (1986). Basidiomycete mycelia and spore-allergen extracts: Skin test reactivity in adults with symptoms of respiratory allergy. Journal of Allergy and Clinical Immunology. 78(3). 478–485. 69 indexed citations
17.
Lopez, Mandi J., Brian T. Butcher, John E. Salvaggio, et al.. (1985). Basidiomycete Allergy: What Is the Best Source of Antigen?. International Archives of Allergy and Immunology. 77(1-2). 169–170. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026